Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Developing effective combination therapy for pancreatic cancer: An overview
Aubrey L. Miller, Patrick L. Garcia, Karina J. Yoon
Pharmacological Research (2020) Vol. 155, pp. 104740-104740
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer
Motahareh Mortazavi, Fatemeh Moosavi, Miriam Martini, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 176, pp. 103749-103749
Closed Access | Times Cited: 80
Role of hypoxia in the tumor microenvironment and targeted therapy
Gaoqi Chen, Kaiwen Wu, Hao Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 62
Research progress of microrobots in tumor drug delivery
Jin Wang, Zhi‐Xin Liao
Food & medicine homology. (2024) Vol. 1, Iss. 2, pp. 9420025-9420025
Closed Access | Times Cited: 9
Extracellular vesicle-mediated crosstalk between pancreatic cancer and stromal cells in the tumor microenvironment
Ying Li, Wenjing Zhao, Yanli Wang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 33
Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity
Fumimasa Tomooka, Kosuke Kaji, Norihisa Nishimura, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 687-687
Open Access | Times Cited: 17
Combination treatment of T1-44, a PRMT5 inhibitor with Vactosertib, an inhibitor of TGF-β signaling, inhibits invasion and prolongs survival in a mouse model of pancreatic tumors
Eunji Hong, Wojciech Barczak, Sujin Park, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 16
Functional Roles of Bromodomain Proteins in Cancer
Samuel P. Boyson, Cong Gao, Kathleen Quinn, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3606-3606
Open Access | Times Cited: 38
Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities
Aditi Jain, Vikas Bhardwaj
World Journal of Gastroenterology (2021) Vol. 27, Iss. 39, pp. 6527-6550
Open Access | Times Cited: 33
Hernandezine induces autophagic cell death in human pancreatic cancer cells via activation of the ROS/AMPK signaling pathway
Changfeng Song, Yuheng Hu, Zhi-Guo Mang, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 4, pp. 865-876
Open Access | Times Cited: 26
The circadian clock as a potential biomarker and therapeutic target in pancreatic cancer
Ghazaleh Pourali, Amir Mahmoud Ahmadzade, Mahshid Arastonejad, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 5, pp. 1243-1255
Closed Access | Times Cited: 13
M6A Regulatory Genes Play an Important Role in the Prognosis, Progression and Immune Microenvironment of Pancreatic Adenocarcinoma
Fangshi Xu, Zhengliang Zhang, Yuan Miao, et al.
Cancer Investigation (2020) Vol. 39, Iss. 1, pp. 39-54
Open Access | Times Cited: 35
Advanced Nanoengineering Approach for Target‐Specific, Spatiotemporal, and Ratiometric Delivery of Gemcitabine–Cisplatin Combination for Improved Therapeutic Outcome in Pancreatic Cancer
Mubin Tarannum, Md Akram Hossain, Bryce Holmes, et al.
Small (2021) Vol. 18, Iss. 2
Open Access | Times Cited: 28
A Phase 2 study of nivolumab in combination with modified FOLFIRINOX for metastatic pancreatic cancer
Chigusa Morizane, Makoto Ueno, Masafumi Ikeda, et al.
BJC Reports (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 4
Overcoming immunotherapeutic drug resistance in pancreatic and colon cancers
Mario Tavakoli, Hasan Raza, Dirin Ukwade, et al.
Elsevier eBooks (2025), pp. 305-324
Closed Access
SEMA3C Supports Pancreatic Cancer Progression by Regulating the Autophagy Process and Tumor Immune Microenvironment
Dalin Zhang, Aaron Lindstrom, Edward Kim, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 18
Local Sustained Chemotherapy of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Injection of Biodegradable Thermo-Sensitive Hydrogel
Dan Yang, Jing Ning, Xiaomin Liao, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 3989-4005
Open Access | Times Cited: 9
Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR Pathways
Dmitri Kamashev, Nina Shaban, Timofey Lebedev, et al.
Cells (2023) Vol. 12, Iss. 16, pp. 2022-2022
Open Access | Times Cited: 9
Hindering the unlimited proliferation of tumor cells synergizes with destroying tumor blood vessels for effective cancer treatment
Ya Liu, Yajun Xu, Ying Wang, et al.
Biomaterials Science (2024) Vol. 12, Iss. 5, pp. 1294-1306
Closed Access | Times Cited: 3
The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer
Aubrey L. Miller, Patrick L. Garcia, Samuel C. Fehling, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3470-3470
Open Access | Times Cited: 21
ZNF655 accelerates progression of pancreatic cancer by promoting the binding of E2F1 and CDK1
Zhuo Shao, Chenggang Li, Qiao Wu, et al.
Oncogenesis (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 14
miR-421 up-regulation by the oleanolic acid derivative K73-03 regulates epigenetically SPINK1 transcription in pancreatic cancer cells leading to metabolic changes and enhanced apoptosis
Abdullah Shopit, Xiaodong Li, Zhongyuan Tang, et al.
Pharmacological Research (2020) Vol. 161, pp. 105130-105130
Closed Access | Times Cited: 23
Circadian Genes as Therapeutic Targets in Pancreatic Cancer
María García-Costela, Julia Escudero-Feliú, Jose D. Puentes-Pardo, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 21
Iridium- and Palladium-Based Catalysts in the Pharmaceutical Industry
Óscar López, José M. Padrón
Catalysts (2022) Vol. 12, Iss. 2, pp. 164-164
Open Access | Times Cited: 13
Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment
Arata Nishimoto
World Journal of Gastroenterology (2022) Vol. 28, Iss. 28, pp. 3637-3643
Open Access | Times Cited: 13
The ethyl acetate extract of Vernonia amygdalina leaf ameliorates gemcitabine effect against migration and invasion of PANC-1 cells via down-regulation the VEGF, COX2, and RAS/MEK pathways
Poppy Anjelisa Zaitun Hasibuan, Jane Melita Keliat, Muhammad Fauzan Lubis, et al.
Saudi Pharmaceutical Journal (2023) Vol. 32, Iss. 1, pp. 101872-101872
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top